Henry Schein EBIT 2010-2024 | HSIC

Henry Schein EBIT for the quarter ending December 31, 2024 was $0.155B, a 297.44% increase year-over-year.

  • Henry Schein 2024 EBIT was 0.621B, a 0.98% increase from 2023.
  • Henry Schein 2023 EBIT was 0.615B, a 17.67% decline from 2022.
  • Henry Schein 2022 EBIT was 0.747B, a 12.32% decline from 2021.

EBIT can be defined as earnings before interest and taxes.

Henry Schein EBIT 2010-2024 | HSIC

  • Henry Schein 2024 EBIT was 0.621B, a 0.98% increase from 2023.
  • Henry Schein 2023 EBIT was 0.615B, a 17.67% decline from 2022.
  • Henry Schein 2022 EBIT was 0.747B, a 12.32% decline from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Labcorp (LH)$18.2B
Cooper (COO)$15.9B
West Pharmaceutical Services (WST)$14.6B
Align Technology (ALGN)$12.5B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M